- Home
- PBA vs BNTX Comparison
PBA vs BNTX Comparison
Compare PBA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBA | BNTX |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | Canada | Germany |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.6B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PBA | BNTX |
|---|---|---|
| Price | $38.55 | $96.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $137.40 |
| AVG Volume (30 Days) | 1.2M | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.01 | N/A |
| Revenue | ★ $5,750,633,574.00 | $3,698,814,972.00 |
| Revenue This Year | $7.53 | $2.03 |
| Revenue Next Year | $3.87 | N/A |
| P/E Ratio | $19.16 | ★ N/A |
| Revenue Growth | ★ 13.22 | 3.70 |
| 52 Week Low | $34.13 | $81.20 |
| 52 Week High | $42.40 | $129.27 |
Technical Indicators
Market Signals| Indicator | PBA | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 51.70 |
| Support Level | $36.72 | $94.00 |
| Resistance Level | $38.33 | $95.71 |
| Average True Range (ATR) | 0.65 | 1.72 |
| MACD | 0.06 | 0.62 |
| Stochastic Oscillator | 69.66 | 81.33 |
Price Performance
Historical ComparisonAbout PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.